Abstract:Research on new antitumor drugs is of great significance since most of the currently available drugs had the disadvantages of high toxicity,low effection and multidrug resistance against subset of solid tumors.Structure modification of natural products may still deliver new hope for antitumor drug discovery.Curcumin and flavonoids are two kinds of important natural products with antitumor activity for recent years.Based on SAR of curcuminoids and our previous work,15 new novel curcumin analogues were designed and synthesized according to pharmacophore and scaffold hopping principle.Structurally,the new analogues are 1,5-diarylpentadienones which possess one nitrogen-containing substitution at the position 5 on one of the aromatic ring.The target compounds 6a-6n and 6o were obtained using 4-hydroxy-3-methoxybenzaldehyde and 2,4-dihydroxybenzaldehyde as starting materials,respectively.After a series of reactions,and the new compounds were finally obtained via Mannich reaction.The structure of new compounds were confirmed by MS(ESI) and 1H-NMR.All of the new compounds were screened for antiproliferation activity against two human tumor cell lines in vitro.Most of the new analogues showed more potent antiproliferation activitities against both tested cells,than that of curcumin,with IC50 values below 10 μmol · L-1.The substituted groups introduced in the aromatic ring didn't make significant effect on their activity.The IC50 value of compound 6c and 6b was lower than that of curcumin and chalcone.The results indicated that compounds with alkaline groups,especially morpholine group,resulted in stronger potent activities.Compounds with cyclohexone(6m,6n) showed decreased activities than that with straight carbon chain(6a).Also,compounds with the second alkaline side chain(6h,6k) did not enhance the activities.The compound(6l) introduced a methy group at 4-position obviously resulted in the decreased antitumor activity.In summary,new compounds with five-carbon chain exhibited more potent activities than those with seven-carbon or three-carbon chain.However,substituted groups were introduced at the 4-positon and 2-position resulted in the decreased bioactivities of compounds.And compounds with a chlorine at the 2-position or trifluoromethyl at the 4-position of ring B enhanced antitumor activities.And the'drug-like' properties predicted by Discovery Studio 2.0 suggested that most of them may be well absorbed by intestine and have good bioavailability.

Cover Feature: Zn(II)‐Curcumin Complexes‐Based Anticancer Agents (ChemMedChem 23/2024)

Zn(II)‐curcumin complexes‐based anticancer agents

Polypyridyl CoII -Curcumin Complexes as Photoactivated Anticancer and Antibacterial Agents

Complexes of Zn( ii ) with a mixed tryptanthrin derivative and curcumin chelating ligands as new promising anticancer agents

Cover Feature: Photoactivated Anticancer Activity of Cobalt(III) Complexes with Naturally Occurring Flavonoids Chrysin and Silibinin (ChemBioChem 20/2024)

Two Copper(Ii) Complexes of Curcumin Derivatives: Synthesis, Crystal Structure and in Vitro Antitumor Activity

Bifunctional Ruthenium(ii) Polypyridyl Complexes of Curcumin As Potential Anticancer Agents

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Synthesis and Antitumor Activity Study of Nitrogen-Containing Curcumin Derivatives

Synthesis and crystal structure of a novel copper(II) complex of curcumin-type and its application in in vitro and in vivo imaging

Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.

Ruthenium(II) Arene Complexes of Curcuminoids: Synthesis, X-ray Diffraction Structure and Cytotoxicity

The progresses in curcuminoids-based metal complexes: especially in cancer therapy.

Copper-Curcumin-Bipyridine Dicarboxylate Complexes as Anticancer Candidates

Computer‐Aided Investigation of Anticancer Properties of New Mixed‐Ligand Cu (II) Complexes of an Unsymmetrical Schiff Base Ligand by ADMET and Molecular Docking: Comparison With Chemical Drugs and Curcumin

Crystal structure, in vitro cytotoxicity, DNA binding and DFT calculations of new copper (II) complexes with coumarin-amide ligand

Unveiling the molecular interplay between a novel chromene derivative and DNA: a multifaceted investigation

Bifunctional tetrazole–carboxylate ligand based Zn(II) complexes: synthesis and their excellent potential anticancer properties

Preparation, Two-Photon Absorption, and Bioimaging Application of a Curcumin-Based Copper(II) Complex

Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells

Novel bifluorescent Zn(II)–cryptolepine–cyclen complexes trigger apoptosis induced by nuclear and mitochondrial DNA damage in cisplatin-resistant lung tumor cells